Ambrogio Curtolo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES	2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES	2024
Efficacy of Fosfomycin-Containing Regimens in Treating Severe Infections Caused by KPC-Producing Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2024
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended	JOURNAL OF CLINICAL MEDICINE	2023
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES	2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature	NEW MICROBIOLOGICA	2022
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared	ANTIBIOTICS	2022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study	INFECTION	2022
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study	JAC-ANTIMICROBIAL RESISTANCE	2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study	INFECTION	2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w)	INFECTION	2022
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia	FRONTIERS IN IMMUNOLOGY	2021
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside	ANTIBIOTICS	2021
Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia	LE INFEZIONI IN MEDICINA	2021
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization	LE INFEZIONI IN MEDICINA	2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)	CARDIOVASCULAR DIABETOLOGY	2020
Are Follow-Up Blood Cultures useful in the antimicrobial management of gram negative bacteremia? A reappraisal of their role based on current knowledge	ANTIBIOTICS	2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial	JOURNAL OF TRANSLATIONAL MEDICINE	2020